316 related articles for article (PubMed ID: 34247053)
21. Characteristics of cerebral ischemic stroke based on moyamoya disease and atherosclerosis-associated intracranial arterial stenosis.
Chen Z; Wu X; Zhou D; Shang S; Ding Y; Ji X; Meng R
Neurol Sci; 2022 Feb; 43(2):1087-1096. PubMed ID: 34106367
[TBL] [Abstract][Full Text] [Related]
22. More Precise Imaging Analysis and Diagnosis of Moyamoya Disease and Moyamoya Syndrome Using High-Resolution Magnetic Resonance Imaging.
Yu LB; He H; Zhao JZ; Wang R; Zhang Q; Shi ZY; Shao JS; Zhang D
World Neurosurg; 2016 Dec; 96():252-260. PubMed ID: 27576769
[TBL] [Abstract][Full Text] [Related]
23. Factors Associated with Stroke Coding Quality: A Comparison of Registry and Administrative Data.
Ryan OF; Riley M; Cadilhac DA; Andrew NE; Breen S; Paice K; Shehata S; Sundararajan V; Lannin NA; Kim J; Kilkenny MF
J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105469. PubMed ID: 33253990
[TBL] [Abstract][Full Text] [Related]
24. Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease.
Chen JB; Liu Y; Zhou LX; Sun H; He M; You C
J Neurosurg; 2016 May; 124(5):1215-20. PubMed ID: 26406790
[TBL] [Abstract][Full Text] [Related]
25. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
[TBL] [Abstract][Full Text] [Related]
27. Clinical features and disease progression in moyamoya disease patients with Graves disease.
Chen JB; Lei D; He M; Sun H; Liu Y; Zhang H; You C; Zhou LX
J Neurosurg; 2015 Oct; 123(4):848-55. PubMed ID: 25859801
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of Moyamoya Syndrome in Pediatric Patients With Neurofibromatosis Type 1.
Brosius SN; Vossough A; Fisher MJ; Lang SS; Beslow LA; George BJ; Ichord R
Pediatr Neurol; 2022 Sep; 134():85-92. PubMed ID: 35849956
[TBL] [Abstract][Full Text] [Related]
29. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics and long-term outcomes of moyamoya syndrome associated with neurofibromatosis type 1.
Han C; Yang WZ; Zhang HT; Ye T; Duan L
J Clin Neurosci; 2015 Feb; 22(2):286-90. PubMed ID: 25443089
[TBL] [Abstract][Full Text] [Related]
31. Characteristics and outcomes of stroke hospitalizations in patients with sickle cell disease and moyamoya syndrome.
Rallo MS; Akel O; Kalakoti P; Sun H
J Stroke Cerebrovasc Dis; 2022 Oct; 31(10):106705. PubMed ID: 35964532
[TBL] [Abstract][Full Text] [Related]
32. Difference in Cerebral Circulation Time between Subtypes of Moyamoya Disease and Moyamoya Syndrome.
Kang K; Lu J; Zhang D; Li Y; Wang D; Liu P; Li B; Ju Y; Zhao X
Sci Rep; 2017 May; 7(1):2587. PubMed ID: 28566764
[TBL] [Abstract][Full Text] [Related]
33. Nationwide survey on quasi-moyamoya disease in Japan.
Hayashi K; Horie N; Izumo T; Nagata I
Acta Neurochir (Wien); 2014 May; 156(5):935-40. PubMed ID: 24499994
[TBL] [Abstract][Full Text] [Related]
34. Ischemic Stroke in Young Adults with Moyamoya Disease: Prognostic Factors for Stroke Recurrence and Functional Outcome after Revascularization.
Zhao M; Deng X; Gao F; Zhang D; Wang S; Zhang Y; Wang R; Zhao J
World Neurosurg; 2017 Jul; 103():161-167. PubMed ID: 28408257
[TBL] [Abstract][Full Text] [Related]
35. Association of apolipoprotein E gene polymorphism with small-vessel lesions and stroke type in moyamoya disease: a preliminary study.
Jang DK; Huh PW; Lee KS
J Neurosurg; 2016 Jun; 124(6):1738-45. PubMed ID: 26566210
[TBL] [Abstract][Full Text] [Related]
36. Revascularization Surgery in Patients with Ischemic-Type Moyamoya Disease: Predictors for Postoperative Stroke and Long-Term Outcomes.
Yu L; Ma L; Huang Z; Shi Z; Wang R; Zhao Y; Zhang D
World Neurosurg; 2019 Aug; 128():e582-e596. PubMed ID: 31059856
[TBL] [Abstract][Full Text] [Related]
37. Blood Pressure Elevation and Risk of Moyamoya Syndrome in Patients With Trisomy 21.
Santoro JD; Lee S; Mlynash M; Nguyen T; Lazzareschi DV; Kraler LD; Mayne EW; Steinberg GK
Pediatrics; 2018 Oct; 142(4):. PubMed ID: 30190347
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of ischemic stroke and atrial fibrillation in young patients with migraine national inpatient sample analysis.
Kuybu O; Amireh A; Davis D; Kelley RE; Javalkar V
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104972. PubMed ID: 32689612
[TBL] [Abstract][Full Text] [Related]
39. The natural history of moyamoya in a North American adult cohort.
Gross BA; Du R
J Clin Neurosci; 2013 Jan; 20(1):44-8. PubMed ID: 23146211
[TBL] [Abstract][Full Text] [Related]
40. Disparities in the symptomatic presentation of Moyamoya disease in the United States: A nationwide all-payer analysis.
Fuentes AM; Chiu RG; Mehta AI
J Clin Neurosci; 2021 May; 87():92-96. PubMed ID: 33863543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
